Please assess the completion status of the following clinical trial:

Trial Title: 400mcg Sublingual Misoprostol as First Line Treatment

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* uterine size less than 12 weeks lmp~* open cervical os~* current or past vaginal bleeding~* willing to provide contact information for follow-up~* over 18 or with guardian consent~Exclusion Criteria:~* suspicion of ectopic pregnancy~* intrauterine device in place~* bad general health (infection, anemia, shoc)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- misoprostol (Type: EXPERIMENTAL): 400 mcg misoprostol sublingually

Based on this trial design, predict the completion outcome and termination type (if applicable).